The Tata CRISPR test is the world’s first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing COVID-19, it said.Moreover, CRISPR is a futuristic technology that can also be configured for detection of multiple other pathogens in the future.
Commenting on the development, Girish Krishnamurthy, CEO, TATA Medical and Diagnostics Ltd said, “The approval for the Tata CRISPR test for COVID-19 will give a boost to the country’s efforts in fighting the global pandemic.
Category:
Disaster & Management
Latest
How to ship a vaccine at -80 C and other obstacles in the covid fight
Companies may have to transport tiny glass vials thousands of miles while keeping them as cold as the South Pole in the depths of winter.
A recent study by DHL and McKinsey found that a cold vaccine would be accessible to about 2.5 billion people in 25 countries. Large parts of Africa, South America and Asia, where super-cold freezers are sparse, would be left out.
“The consequence is to reinforce the staggering bias in favor of the wealthy and powerful few countries,” said Morrison, of the Center for Strategic and International Studies.
World’s top companies urge action on nature loss ahead of U.N. talks
“Healthy societies, resilient economies and thriving businesses rely on nature. Governments must adopt policies now to reverse nature loss in this decade,” the companies said in a statement.
Others to sign included IKEA, Unilever and AXA .
Business for Nature, the coalition which organised the statement, said it was the first time so many companies had issued a joint call emphasising the crucial role healthy ecosystems play in human well-being.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.